WilliamPTewMD

Gynecologic Cancer, Hematologic Oncology

Attending Physician, Memorial Sloan Kettering Cancer Center

Overview of Dr. Tew

Dr. William Tew is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice 18 years. He specializes in gynecologic cancer and hematologic oncology and is experienced in gynecologic oncology and geriatric assessment.

Office
160 East 53rd Street
New York, NY 10022
Book by Phone+1(636) 486-3136

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
NYU Grossman School of MedicineResidency, Internal Medicine, 1999 - 2003
University of Rochester School of Medicine and DentistryClass of 1999

Certifications & Licensure

FL State Medical License 2021 - Present
NY State Medical License 2000 - 2026
NJ State Medical License 2019 - 2025
American Board of Internal Medicine Medical Oncology

Clinical Trials

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Start of enrollment: 2004 Jan 01
Completed
Phase 1
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma Start of enrollment: 2004 Jan 01
Completed
Phase 1
Assessment Tool for Older Patients With Cancer Start of enrollment: 2006 Dec 19
Active, not recruiting
Not Applicable
Sorafenib in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in at Least the Second Remission Start of enrollment: 2007 Jul 01
Terminated
Phase 2
Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 27
Completed
Phase 2
Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer Start of enrollment: 2011 Nov 01
Active, not recruiting
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study Start of enrollment: 2011 Sep 09
Active, not recruiting
A Study of a Telemedicine Program for Older Adults With Cancer Start of enrollment: 2021 Jun 01
Active, not recruiting
Roles: Contact
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy Start of enrollment: 2019 Dec 16
Active, not recruiting
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ova...
Jubilee Brown, Austin Miller, Laura L Holman, Floor Backes, Christa Nagel
Gynecologic Oncology. 2024-11-01
Vascular resection and reconstruction in recurrent granulosa cell tumor.
Lindsey Finch, Sharif Ellozy, Jaspreet Sandhu, Tulsi Patel, William P Tew
Gynecologic Oncology Reports. 2024-10-01
Homologous recombination deficiency should be tested for in patients with advanced stage high-grade serous ovarian cancer aged 70 years and over.
Omali Pitiyarachchi, Peter J Ansell, Robert L Coleman, Minh H Dinh, Laura Holman
Gynecologic Oncology. 2024-08-01

Journal Articles

A Phase 1 Dose-Escalation Study of Intraperitoneal Cisplatin, intravenous/intraperitoneal Paclitaxel, Bevacizumab, and Olaparib for Newly Diagnosed Ovarian Cancer
Karen A Cadoo, Roisin E O'Cearbhaill, Dmitriy Zamarin, Paul J Sabbatini, William P Tew, Carol Aghajanian, Jason A Konner, Gynecologic Oncology

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment